Health Condition 1: C169- Malignant neoplasm of stomach, unspecified Health Condition 2: null- Stomach and Colorectal cancer patients on chemotherapy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Provide informed consent and sign the patient information sheet - Own a mobile phone with text message (SMS) facility. - Diagnosed with stomach cancer (all histological types) and are planned for peri-operative chemotherapy (before surgery) with EOX protocol i.e. combination of Epirubicin, Oxaliplatin and Capecitabine given every 3 weeks. - Diagnosed with colorectal cancer (post-surgery and/or radiotherapy, including metastatic disease) and planned to start on adjuvant or palliative chemotherapy with CapOx protocol i.e. combination of Capecitabine and Oxaliplatin given every 3 weeks. - Residing within 50km radius of TMC. - Patient or any of his/her immediate family member(s) who are able to read and comprehend text message in English
Exclusion criteria
Exclusion criteria: - Not a citizen of India e.g. patients from neighbouring countries like Bangladesh, Nepal, Bhutan. - Non-resident Indians i.e. Indians residing outside India but visiting India for cancer treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Number of Suspected Unexpected Serious Adverse Reactions (SUSARs) - Number of delayed chemotherapy cycles due to toxicity - Number of dose reductions due to severe toxicity Timepoint: NA | — |
Secondary
| Measure | Time frame |
|---|---|
| - Overall cost of treatment and out of pocket expenditureTimepoint: NA | — |
Countries
India
Contacts
Tata Medical Center